Form 4 for ALT Altimmune, Inc.
Accepted 2022-11-21 00:00:00 ET · period of report 2022-11-18 · accession 0001104659-22-120752 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-21 | 2022-11-18 | ALT | Drutz David | Dir | M - OptEx | $2.40 | +139 | 20.2K | +0.7% | +$333.60 |
| D | 2022-11-21 | 2022-11-18 | ALT | Drutz David | Dir | M - OptEx | $0.00 | -139 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2022-11-18 | M | A | 139 | $2.40 | 20,151 | D | — | — | |
| 2 | Derivative | Stock Options (option to buy) | 2022-11-18 | M | D | 139 | $0.00 | 0 | D | $2.40 · — to 2022-12-31 | 139 Common Stock, par value $0.0001 | (F2) This option was previously reported as covering 4,178 shares at an exercise price of $0.08 per share, but was adjusted to reflect a one-for-thirty reverse stock split that occurred on September 13, 2018. (F3) This option is fully vested and exercisable as of the date hereof. |